drugset
Drugs / SA14-14-2
last change Jan 2017 re-read 3 minutes ago

SA14-14-2

also known as JE vaccine SA14-14-2

Vaccine

Developed for
Japanese encephalitis
Investigated by
Indian Institute of Science · National Institute of Mental Health and Neuro Sciences, India · PATH · University of Liverpool · Wellcome Trust

Trials 1

today NCT01656200 · Ph 4
2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT01656200 May 2012 → Oct 2013 Japanese encephalitis Indian Institute of Science Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as SA14-14-2 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01656200 ↗
Known as JE vaccine SA14-14-2 “We used live attenuated JE vaccine SA14-14-2 as a model for studying T cell responses to JEV infection in adults” PMID 28135273 ↗ Jan 2017
Modality Vaccine “Japanese encephalitis (JE) live attenuated vaccine SA14-14-2 has been in use for more more than 20 years in Asia.” NCT01656200 ↗